Gilead BENEFITS from Competitor’s Suspension and 4 Stock Analyses Impacting the Market

Ameristar Casinos Inc. (NASDAQ:ASCA) target was lowered by RBC Capital after the company reported lower Q2 adjusted EPS than expected. The firm reduced its estimates but keeps an Outperform rating.

Don’t Miss: Are These 5 TOP Stock Performers Overbought?

DaVita, Inc. (NYSE:DVA) target was raised by RBC Capital after the company reported in-line Q2 adjusted EPS. The firm thinks that the company reported solid organic volumes and it keeps an Outperform rating on the stock.

Guess? Inc. (NYSE:GES) shares may be under pressure following Abercrombie & Fitch’s (NYSE:ANF) issuance of a negative Q2 pre-announcement, according to Piper Jaffray. The firm states that it is increasingly concerned about European-exposed companies, and it reduced its Q2 estimate for Guess to 46c from 48c. The firm reiterates a Neutral rating and reduces its price target to $27 from $28 on the stock.

NICE Systems Ltd. (NASDAQ:NICE) target has been lowered by RBC Capital after the company provided weaker Q3 adjusted EPS guidance than expected. The firm keeps an Outperform rating due to citing valuation.

Gilead Sciences Inc. (NASDAQ:GILD): Following Bristol-Myers’ (NYSE:BMY) announcement that it was halting its INX-189 drug because of a serious safety issue, RBC Capital thinks that this development could raise the value of Gilead’s GS-7977 while simultaneously removing a main competitor. The firm keeps an Outperform rating on the stock.

Don’t Miss: Apple Talent Getting POACHED.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.